0001685307-16-000001.txt : 20160921 0001685307-16-000001.hdr.sgml : 20160921 20160921135732 ACCESSION NUMBER: 0001685307-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160921 DATE AS OF CHANGE: 20160921 EFFECTIVENESS DATE: 20160921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immune-Onc Therapeutics, Inc. CENTRAL INDEX KEY: 0001685307 IRS NUMBER: 812180798 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271031 FILM NUMBER: 161895428 BUSINESS ADDRESS: STREET 1: 1059 EAST MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-460-8898 MAIL ADDRESS: STREET 1: 1059 EAST MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 D 1 primary_doc.xml X0707 D LIVE 0001685307 Immune-Onc Therapeutics, Inc. 1059 EAST MEADOW CIRCLE PALO ALTO CA CALIFORNIA 94303 650-460-8898 DELAWARE None None Corporation true 2015 Xiaoling Charlene Liao 1059 East Meadow Circle Palo Alto CA CALIFORNIA 94303 Executive Officer Director Liqun Luo 1059 East Meadow Circle Palo Alto CA CALIFORNIA 94303 Director Guo-Liang Yu 1059 East Meadow Circle Palo Alto CA CALIFORNIA 94303 Director Biotechnology Decline to Disclose 06b false 2016-07-01 false true true Conversion of Promissory Note false 1 7003890 7003890 0 false 14 0 0 0 true false Immune-Onc Therapeutics, Inc. /s/Xiaoling Charlene Liao Xiaoling Charlene Liao President & CEO 2016-09-21